Phospholipid derivatives of DHA and methods for treating respiratory failure using the same
OwnerGérard Pieroni, Thierry Costeinventors
Life of this patent
Estimating the term…
Abstract
Taught are pharmaceutical compositions comprising at least one phospholipid having at least one docosahexaenoyl (DHA) residue, such as a lecithin-DHA-type phospholipid, and methods for treating or preventing respiratory failure of a patient comprising administering these pharmaceutical compositions to a patient in need of such treatment or prevention.
Claims15
A method for treating respiratory failure of a patient comprising administering to a patient in need of such treatment a pharmaceutical composition comprising a pharmaceutically-acceptable excipient and at least one phospholipid of the general formula (I)
- wherein
- one of R1 or R2 represents a docosahexaenoyl (DHA) and the other represents a saturated or unsaturated acyl group containing 8 to 24 carbon atoms, or both R1 and R2 represent independently and at each occurrence a docosahexaenoyl group (DHA);
- and
- R3 represents a choline group, a serine group, an ethanolamine group, an inositol group, a glycerol group, or hydrogen.
A method for treating respiratory failure of a patient comprising administering to a patient in need of such treatment a pharmaceutical composition comprising:
- (a) a pharmaceutically-acceptable excipient and (b) DHA-enriched egg or DHA-enriched egg extracts.
A method for treating respiratory failure of a patient comprising administering to a patient in need of such treatment a pharmaceutical composition comprising (a) a pharmaceutically-acceptable excipient and (b) DHA-enriched egg or DHA-enriched egg extracts, wherein said DHA-enriched egg or said DHA-enriched egg extracts comprise DHA enriched egg lecithin.
A method for treating respiratory failure of a patient comprising administering to a patient in need of such treatment a pharmaceutical composition comprising (a) a pharmaceutically-acceptable excipient and (b) DHA-enriched egg or DHA-enriched egg extracts, wherein said DHA-enriched egg or said DHA-enriched egg extracts comprise egg yolk powder.
Dependencies are inferred from the claim text.